107 related articles for article (PubMed ID: 1428696)
1. [Pharmacodynamics of piretanide in compromised kidney function. Dose response relationship and equipotency with furosemide].
Keller E; Reetze-Bonorden P; Rambauseck M; Pooth R
Internist (Berl); 1992 Aug; 33 Suppl 1():S36-8. PubMed ID: 1428696
[No Abstract] [Full Text] [Related]
2. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
Sjöström P
Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of high dose furosemide in patients with chronic renal failure or nephrotic syndrome.
Kühnel HJ; Günther K; Stein G; Hoffmann-Traeger A
Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):616-21. PubMed ID: 3429064
[TBL] [Abstract][Full Text] [Related]
4. [Diuretic therapy in moderate and advanced renal failure].
Stein G
Internist (Berl); 1992 Aug; 33 Suppl 1():S31-4. PubMed ID: 1428694
[No Abstract] [Full Text] [Related]
5. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
Vargo DL; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
[TBL] [Abstract][Full Text] [Related]
6. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.
Vasavada N; Saha C; Agarwal R
Kidney Int; 2003 Aug; 64(2):632-40. PubMed ID: 12846760
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and pathophysiologic effects of piretanide in nephrotic syndrome].
Plum J; Plum F; Pooth R; Grabensee B
Internist (Berl); 1992 Aug; 33 Suppl 1():S39-45. PubMed ID: 1428697
[No Abstract] [Full Text] [Related]
8. NXY-059 does not significantly interact with furosemide in healthy volunteers.
Strid S; Nilsson D; Borgå O; Wemer J; Grahnén A
J Clin Pharmacol; 2006 Dec; 46(12):1417-25. PubMed ID: 17101741
[TBL] [Abstract][Full Text] [Related]
9. The short-term effect of furosemide on electrolyte and water excretion in patients with severe renal disease.
Gregory LF; Durrett RR; Robinson RR; Clapp JR
Arch Intern Med; 1970 Jan; 125(1):69-74. PubMed ID: 5410655
[No Abstract] [Full Text] [Related]
10. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
Klütsch K; Grosswendt J; Haecker W
Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics and effect of furosemide in patients with impaired kidney function].
Traeger A; Stein H; Sperschneider A; Leil E
Farmakol Toksikol; 1982; 45(3):112-4. PubMed ID: 7095122
[No Abstract] [Full Text] [Related]
12. [The pharmacodynamics and pharmacokinetics of furosemide during ordinary life activities and during head-down tilt hypokinesia in a healthy subject].
Noskov VB; Goncharov IV; Kovachevich IV; Repenkova LG; Kodratenko SN; Starodubtsev AK
Eksp Klin Farmakol; 1998; 61(4):29-33. PubMed ID: 9783105
[TBL] [Abstract][Full Text] [Related]
13. [Hear failure. Indications for diuretic therapy in general practice].
MMW Fortschr Med; 2003 May; 145(18):55. PubMed ID: 12808825
[No Abstract] [Full Text] [Related]
14. [Effect of piretanide on disorders of kidney function in kidney transplantation. A pilot project].
Abendroth D; Pooth R; Schneeberger H; Land W
Internist (Berl); 1992 Aug; 33 Suppl 1():S6-9. PubMed ID: 1428700
[No Abstract] [Full Text] [Related]
15. A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease.
Dussol B; Moussi-Frances J; Morange S; Somma-Delpero C; Mundler O; Berland Y
J Clin Hypertens (Greenwich); 2012 Jan; 14(1):32-7. PubMed ID: 22235821
[TBL] [Abstract][Full Text] [Related]
16. [How can improved effectiveness of the loop diuretic furosemide be explained when the same dosage is administered 2 x daily (morning and noon)?].
Steffgen J
Internist (Berl); 1996 Apr; 37(4):400-1. PubMed ID: 8655279
[No Abstract] [Full Text] [Related]
17. [Diuretics and their potential effect on breath-alcohol concentration--a case report].
Schmitt G; Skopp G
Arch Kriminol; 2015; 235(5-6):172-81. PubMed ID: 26427279
[TBL] [Abstract][Full Text] [Related]
18. [Use of high-dose furosemide in patients undergoing regular hemodialysis].
Ragni R; Stratta P; Dogliani M; Segoloni G; Piccoli G
Minerva Med; 1972 Oct; 63(70):3797-805. PubMed ID: 5079121
[No Abstract] [Full Text] [Related]
19. Renal responses and pharmacokinetics of piretanide in humans: effect of route of administration, state of hydration and probenecid pretreatment.
Noormohamed FH; McNabb WR; Dixey JJ; Lant AF
J Pharmacol Exp Ther; 1990 Sep; 254(3):992-9. PubMed ID: 2395126
[TBL] [Abstract][Full Text] [Related]
20. [Features of the pharmacodynamics and pharmacokinetics of furosemide upon long-term administration in rats].
Briukhanov VM; Zverev IaF; Lampatov VV; Zharikov AIu
Eksp Klin Farmakol; 2007; 70(2):33-6. PubMed ID: 17523448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
